Drug factsFDA approves Valbenazine to treat tardive dyskinesia
Tardive dyskinesia is a neurological disorder characterized by repetitive involuntary movements, usually of the jaw, lips and tongue, such as grimacing, sticking out the tongue and smacking the lips. Some affected people also experience involuntary movement of the extremities or difficulty breathing. Video showing the Case: Valbenazine: The U.S. Food and Drug Administration today approved…
Apr 11, 2017
